Novavax is a biotech company that creates vaccines to prevent infectious diseases. Their vaccine portfolio includes influenza, respiratory syncytial virus, and a COVID-19 candidate vaccine. The company is currently in Phase III clinical trials for their COVID-19 vaccine and is collaborating with Takeda for its development and commercialization.